206 related articles for article (PubMed ID: 37767081)
1. Identification of potential biological targets of oxindole scaffolds via
Tinivella A; Pinzi L; Gambacorta G; Baxendale I; Rastelli G
F1000Res; 2022; 11():. PubMed ID: 37767081
[No Abstract] [Full Text] [Related]
2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
3. Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing.
Bernal L; Pinzi L; Rastelli G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834548
[TBL] [Abstract][Full Text] [Related]
4. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
Johnston TH; Lacoste AMB; Visanji NP; Lang AE; Fox SH; Brotchie JM
Neuropharmacology; 2019 Mar; 147():11-27. PubMed ID: 29907424
[TBL] [Abstract][Full Text] [Related]
5. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
6. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
[TBL] [Abstract][Full Text] [Related]
7. Phytochemical Repurposing of Natural Molecule: Sabinene for Identification of Novel Therapeutic Benefits Using
Sharma S; Gupta J; Prabhakar PK; Gupta P; Solanki P; Rajput A
Assay Drug Dev Technol; 2019; 17(8):339-351. PubMed ID: 31846362
[TBL] [Abstract][Full Text] [Related]
8. Application of the 4D fingerprint method with a robust scoring function for scaffold-hopping and drug repurposing strategies.
Hamza A; Wagner JM; Wei NN; Kwiatkowski S; Zhan CG; Watt DS; Korotkov KV
J Chem Inf Model; 2014 Oct; 54(10):2834-45. PubMed ID: 25229183
[TBL] [Abstract][Full Text] [Related]
9. Considerations and challenges for sex-aware drug repurposing.
Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
[TBL] [Abstract][Full Text] [Related]
10. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.
Wang L; Ma C; Wipf P; Liu H; Su W; Xie XQ
AAPS J; 2013 Apr; 15(2):395-406. PubMed ID: 23292636
[TBL] [Abstract][Full Text] [Related]
11. Identify drug repurposing candidates by mining the protein data bank.
Moriaud F; Richard SB; Adcock SA; Chanas-Martin L; Surgand JS; Ben Jelloul M; Delfaud F
Brief Bioinform; 2011 Jul; 12(4):336-40. PubMed ID: 21768131
[TBL] [Abstract][Full Text] [Related]
12. A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors.
Phatak SS; Zhang S
Pac Symp Biocomput; 2013; ():29-40. PubMed ID: 23424109
[TBL] [Abstract][Full Text] [Related]
13. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
Ng YL; Salim CK; Chu JJH
Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
[TBL] [Abstract][Full Text] [Related]
14. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations.
Omer SE; Ibrahim TM; Krar OA; Ali AM; Makki AA; Ibraheem W; Alzain AA
Biochem Biophys Rep; 2022 Mar; 29():101225. PubMed ID: 35128086
[TBL] [Abstract][Full Text] [Related]
16. Innovative target mining stratagems to navigate drug repurposing endeavours.
Saravanan KS; Satish KS; Saraswathy GR; Kuri U; Vastrad SJ; Giri R; Dsouza PL; Kumar AP; Nair G
Prog Mol Biol Transl Sci; 2024; 205():303-355. PubMed ID: 38789185
[TBL] [Abstract][Full Text] [Related]
17. A data-driven methodology towards evaluating the potential of drug repurposing hypotheses.
Prieto Santamaría L; Ugarte Carro E; Díaz Uzquiano M; Menasalvas Ruiz E; Pérez Gallardo Y; Rodríguez-González A
Comput Struct Biotechnol J; 2021; 19():4559-4573. PubMed ID: 34471499
[TBL] [Abstract][Full Text] [Related]
18. A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.
Mutowo P; Bento AP; Dedman N; Gaulton A; Hersey A; Lomax J; Overington JP
J Biomed Semantics; 2016 Sep; 7(1):59. PubMed ID: 27678076
[TBL] [Abstract][Full Text] [Related]
19. SPIDR: small-molecule peptide-influenced drug repurposing.
King MD; Long T; Pfalmer DL; Andersen TL; McDougal OM
BMC Bioinformatics; 2018 Apr; 19(1):138. PubMed ID: 29661129
[TBL] [Abstract][Full Text] [Related]
20. An update on Drug Repurposing: Re-written saga of the drug's fate.
Gns HS; Gr S; Murahari M; Krishnamurthy M
Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
